Stock A067080 DAE HWA PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company DAE HWA Pharmaceutical Co., Ltd.

Equities

A067080

KR7067080002

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-06-27 EDT 		5-day change 1st Jan Change
9,690 KRW -2.12% Intraday chart for DAE HWA Pharmaceutical Co., Ltd. -6.56% +3.30%
2022 DAE HWA Pharmaceutical Co., Ltd.(KOSDAQ:A067080) dropped from S&P Global BMI Index CI
2019 Mediforum Co.,Ltd. acquired 13.9% stake in C-TRI Co., Ltd. from DAE HWA Pharmaceutical Co., Ltd. and Wanjoo Kim for KRW 20.2 billion. CI

Business Summary

DAE HWA PHARM CO.,LTD. is a Korea-based company engaged in the manufacture of pharmaceuticals. The Company’s products include skeletal muscle relaxants, gastro-intestinal drugs, corticosteroids, antihistamines, cardiovascular drugs, drugs for liver diseases, vitamins, tonics, antibiotics, injections, topical drugs, anti-inflammatory enzymes, analgesics, antipyretics, plaster, cough suppressants, expectorants and mucolytics, drugs for hemorrhoid disease and other prescription drugs, as well as over-the-counter (OTC) drugs. The Company distributes its products within domestic market and to overseas markets. On August 22, 2013, it acquired a certain shares of a Korea-based company, which is mainly engaged in the manufacture of medicine raw materials and development of medical devices. After the transaction, the Company held a 100% stake of the Korea-based company.

Number of employees: 308

Sales per Business

KRW in Million2022Weight2023Weight Delta
Pharmaceuticals Manufacturing
74.7 %
99,593 75.5 % 105,549 74.7 % +5.98%
Pharmaceutical Wholesaler
15.7 %
23,225 17.6 % 22,144 15.7 % -4.65%
Cosmetics and Medical Device Manufacturing
4.9 %
5,034 3.8 % 6,891 4.9 % +36.87%
Pharmaceutical Raw Material Manufacturing
4.7 %
3,958 3.0 % 6,694 4.7 % +69.14%
Medical Information System
0.1 %
102 0.1 % 81 0.1 % -20.03%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
91.0 %
117,086 88.8 % 128,628 91.0 % +9.86%
Germany
4.9 %
5,034 3.8 % 6,891 4.9 % +36.87%
Myanmar/Cambodia
1.5 %
2,105 1.6 % 2,117 1.5 % +0.59%
Vietnam
1.0 %
640 0.5 % 1,406 1.0 % +119.61%
Other
0.9 %
2,268 1.7 % 1,226 0.9 % -45.95%
Ecuador/Bolivia
0.8 %
1,162 0.9 % 1,085 0.8 % -6.58%
China
0.0 %
3,617 2.7 % 6 0.0 % -99.84%

Managers

Managers TitleAgeSince
Byung-Tae Noh CEO
 Chief Executive Officer 62 85-12-14
Eun-Seok Kim CEO
 Chief Executive Officer 48 08-01-31
Jae-Seong Na DFI
 Director of Finance/CFO 55 93-01-31
Jae-Gwon Yang CTO
 Chief Tech/Sci/R&D Officer 61 08-09-30
Sang-Tae Lee BRD
 Director/Board Member 59 89-02-28
Shin-Won Bang SAM
 Sales & Marketing 54 -
Tae-Hoon Kim HRO
 Human Resources Officer 49 18-04-30
Boon-Yeon Ahn PRN
 Corporate Officer/Principal 59 92-04-30
Nam-Soo Han PRN
 Corporate Officer/Principal 68 -
Shin-Bae Ji PRN
 Corporate Officer/Principal 60 -

Members of the board

Members of the board TitleAgeSince
Eun-Seok Kim CEO
 Chief Executive Officer 48 08-01-31
Byung-Tae Noh CEO
 Chief Executive Officer 62 85-12-14
Sang-Tae Lee BRD
 Director/Board Member 59 89-02-28
Jae-Gwon Yang CTO
 Chief Tech/Sci/R&D Officer 61 08-09-30
Jong-Il Kim BRD
 Director/Board Member 62 17-03-23
Hye-Seon Jeong BRD
 Director/Board Member 63 18-02-28

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 18,616,650 12,091,717 ( 64.95 %) 1,100,000 ( 5.909 %) 64.95 %

Shareholders

NameEquities%Valuation
Soo-Ji Kim
9.598 %
1,786,792 9.598 % 12 M ₩
Jun-jin Ko
9.168 %
1,706,867 9.168 % 12 M ₩
DAE HWA PHARMACEUTICAL CO., LTD.
5.909 %
1,100,000 5.909 % 8 M ₩
Woon-Jang Kim
4.090 %
761,500 4.090 % 5 M ₩
Han-Gu Lee
3.337 %
621,300 3.337 % 4 M ₩
Myung-hee Lee
1.144 %
213,000 1.144 % 1 M ₩
Eun-Seok Kim
1.047 %
195,000 1.047 % 1 M ₩
Ju-hee Lee
0.2149 %
40,000 0.2149 % 277 058 ₩
Hyung-min Kim
0.1642 %
30,562 0.1642 % 211 686 ₩
Hyung-ryul Kim
0.1504 %
28,000 0.1504 % 193 940 ₩

Holdings

NameEquities%Valuation
DAE HWA PHARMACEUTICAL CO., LTD.
5.91%
 1,100,000 5.91% 7,619,084 $

Company contact information

DAE HWA PHARM Co., Ltd.

495 Hanu-ro Hoengseong-eup

25228, Hoengseong-gun

+

http://www.dhpharm.co.kr
address DAE HWA Pharmaceutical Co., Ltd.(A067080)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Specialty & Advanced Pharmaceuticals

Sales per Business

Sales per region

Sector Specialty & Advanced Pharmaceuticals

1st Jan change Capi.
DAE HWA PHARMACEUTICAL CO., LTD. Stock DAE HWA Pharmaceutical Co., Ltd.
+3.30% 123M
MERCK KGAA Stock Merck KGaA
+7.39% 72.09B
KYOWA KIRIN CO. LTD. Stock Kyowa Kirin Co. Ltd.
+15.93% 9.05B
YUHAN CORPORATION Stock Yuhan Corporation
+17.59% 4.39B
SK BIOPHARMACEUTICALS CO., LTD. Stock SK Biopharmaceuticals Co., Ltd.
-22.81% 4.4B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Stock Shenyang Xingqi Pharmaceutical Co.,Ltd.
+25.93% 3.94B
INDIVIOR PLC Stock Indivior PLC
+4.64% 2.1B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Stock Shanghai Shyndec Pharmaceutical Co., Ltd.
+9.09% 1.97B
BETTA PHARMACEUTICALS CO., LTD. Stock Betta Pharmaceuticals Co., Ltd.
-36.86% 1.87B
VELOXIS PHARMACEUTICALS A/S Stock Veloxis Pharmaceuticals A/S
-0.50% 1.64B
Specialty & Advanced Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A067080 Stock
  4. Company DAE HWA Pharmaceutical Co., Ltd.